DE3751602T2 - Subkutane Verabreichung des humanen Choriongonadotropins. - Google Patents

Subkutane Verabreichung des humanen Choriongonadotropins.

Info

Publication number
DE3751602T2
DE3751602T2 DE3751602T DE3751602T DE3751602T2 DE 3751602 T2 DE3751602 T2 DE 3751602T2 DE 3751602 T DE3751602 T DE 3751602T DE 3751602 T DE3751602 T DE 3751602T DE 3751602 T2 DE3751602 T2 DE 3751602T2
Authority
DE
Germany
Prior art keywords
human chorionic
subcutaneous administration
chorionic gonadotropin
efficaceously
those obtained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3751602T
Other languages
English (en)
Other versions
DE3751602D1 (de
Inventor
Werner Dr Med Saal
Joachim Prof Dr Med Happ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Pharmazeutische Praeparate GmbH
Original Assignee
Serono Pharmazeutische Praeparate GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Pharmazeutische Praeparate GmbH filed Critical Serono Pharmazeutische Praeparate GmbH
Publication of DE3751602D1 publication Critical patent/DE3751602D1/de
Application granted granted Critical
Publication of DE3751602T2 publication Critical patent/DE3751602T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3751602T 1987-05-12 1987-05-12 Subkutane Verabreichung des humanen Choriongonadotropins. Expired - Lifetime DE3751602T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87106858A EP0290644B1 (de) 1987-05-12 1987-05-12 Subkutane Verabreichung des humanen Choriongonadotropins

Publications (2)

Publication Number Publication Date
DE3751602D1 DE3751602D1 (de) 1995-12-21
DE3751602T2 true DE3751602T2 (de) 1996-05-02

Family

ID=8196979

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751602T Expired - Lifetime DE3751602T2 (de) 1987-05-12 1987-05-12 Subkutane Verabreichung des humanen Choriongonadotropins.

Country Status (6)

Country Link
EP (1) EP0290644B1 (de)
JP (1) JPS6445317A (de)
AT (1) ATE130194T1 (de)
DE (1) DE3751602T2 (de)
ES (1) ES2079345T3 (de)
GR (1) GR3018837T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361992B1 (en) 1996-05-08 2002-03-26 The United States Of America As Represented By The Department Of Health And Human Services Thyroid stimulating hormone superagonists
US10457713B2 (en) 2012-07-30 2019-10-29 Trophogen, Inc. Glycoprotein hormone long-acting superagonists
AU2013296709B2 (en) 2012-07-30 2018-03-08 Trophogen Inc. Glycoprotein hormone long-acting superagonists
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CA2929561A1 (en) 2013-11-05 2015-05-14 Trophogen Inc. Glycoprotein hormone long-acting superagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608M (fr) * 1963-02-06 1964-06-22 Organon Nv Préparations a action prolongée de gonadotrophines obtenues a partir d'urine.
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
GB2174600B (en) * 1985-05-10 1989-12-20 Univ Melbourne Induction of ovulation in mares

Also Published As

Publication number Publication date
ATE130194T1 (de) 1995-12-15
JPS6445317A (en) 1989-02-17
EP0290644A1 (de) 1988-11-17
DE3751602D1 (de) 1995-12-21
GR3018837T3 (en) 1996-04-30
ES2079345T3 (es) 1996-01-16
EP0290644B1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
KR890700359A (ko) 안정한 인터페론 복합체
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
DE3875425D1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
ATE61523T1 (de) Mittel zur verabreichung von hyaluronsaeure an saeuger.
MX9204861A (es) Analogos de polipeptidos que tienen actividad liberadora de la hormona de crecimiento.
ES2033259T3 (es) Bases de liberacion controlada de productos farmaceuticos.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DE3751602T2 (de) Subkutane Verabreichung des humanen Choriongonadotropins.
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
NO179436C (no) Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk
ES2019634B3 (es) Terapia con clorfeniramina.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
DE3585835D1 (de) Praeparat zur intramuskulaeren injektion von medikamenten, vitaminen oder impfstoffen.
MX9203339A (es) Tratamiento de enfermedad inflamatoria articular.
FI884911A (fi) Laekemedel, i dessa saosom aktiva aemnen befintliga fosforin innehaollande 2-isoxazoliner och isoxazoler samt foerfarande foer framstaellning av dessa heterocykliska foereningar.
ATE66566T1 (de) Alkoventrennung.
IT8635931V0 (it) Perfezionamento del controllore dell'iniezione di gocce medicinali
DE3778858D1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SERONO PHARMA GMBH, 85716 UNTERSCHLEISSHEIM, DE